Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

BackgroundDostarlimab is a humanized monoclonal antibody that binds with high affinity to PD-1, resulting in inhibition of binding to PD-L1 and PD-L2. We report interim data from patients with endometrial cancer (EC) participating in a phase I trial of single-agent dostarlimab.MethodsGARNET, an ongo...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal for immunotherapy of cancer Ročník 10; číslo 1; s. e003777
Hlavní autori:	Oaknin, Ana, Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O’Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda, Ghamande, Sharad, Ghatage, Prafull, Kristeleit, Rebecca, Leath III, Charles, Guo, Wei, Im, Ellie, Zildjian, Sybil, Han, Xinwei, Duan, Tao, Veneris, Jennifer, Pothuri, Bhavana
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England BMJ Publishing Group Ltd 01.01.2022 BMJ Publishing Group LTD BMJ Publishing Group
Edícia:	Original research
Predmet:	Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Biomarkers Biomarkers, Tumor - metabolism Cancer Cell death clinical trials as topic Clinical/Translational Cancer Immunotherapy DNA Mismatch Repair - drug effects Endometrial cancer Endometrial Neoplasms - drug therapy Enrollments Female Humans Hypotheses Immunotherapy Laboratories Life Sciences Microsatellite Instability - drug effects Middle Aged Monoclonal antibodies Mutation Patients programmed cell death 1 receptor Proteins Response rates Targeted cancer therapy Tumors clinical trials as topic programmed cell death 1 receptor immunotherapy
ISSN:	2051-1426, 2051-1426
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!